Vanguard Group’s Charles River Laboratories CRL Stock Holding History

Vanguard Group’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$1.17B	Buy	5,887,175 +47,432	+0.8%	+$8.6M	0.02%	657
2025 Q3	$914M	Buy	5,839,743 +27,989	+0.5%	+$4.45M	0.01%	748
2025 Q2	$882M	Sell	5,811,754 -293,724	-5%	-$39.2M	0.01%	738
2025 Q1	$919M	Sell	6,105,478 -53,448	-0.9%	-$8.96M	0.02%	681
2024 Q4	$1.14B	Buy	6,158,926 +60,497	+1%	+$11.7M	0.02%	618
2024 Q3	$1.2B	Sell	6,098,429 -5,020	-0.1%	-$1.04M	0.02%	599
2024 Q2	$1.26B	Buy	6,103,449 +56,982	+0.9%	+$12.9M	0.02%	568
2024 Q1	$1.64B	Buy	6,046,467 +66,161	+1%	+$15.8M	0.03%	508
2023 Q4	$1.41B	Buy	5,980,306 +26,446	+0.4%	+$5.2M	0.03%	527
2023 Q3	$1.17B	Buy	5,953,860 +29,482	+0.5%	+$6.05M	0.03%	546
2023 Q2	$1.25B	Sell	5,924,378 -91,343	-2%	-$18.2M	0.03%	537
2023 Q1	$1.21B	Buy	6,015,721 +58,761	+1%	+$13.3M	0.03%	535
2022 Q4	$1.3B	Sell	5,956,960 -20,159	-0.3%	-$4.4M	0.04%	498
2022 Q3	$1.18B	Buy	5,977,119 +7,087	+0.1%	+$1.53M	0.03%	507
2022 Q2	$1.28B	Buy	5,970,032 +34,305	+0.6%	+$8.38M	0.04%	501
2022 Q1	$1.69B	Buy	5,935,727 +66,602	+1%	+$20.5M	0.04%	487
2021 Q4	$2.21B	Sell	5,869,125 -52,925	-0.9%	-$20.6M	0.05%	407
2021 Q3	$2.44B	Buy	5,922,050 +10,416	+0.2%	+$4.33M	0.06%	342
2021 Q2	$2.19B	Buy	5,911,634 +754,558	+15%	+$252M	0.05%	387
2021 Q1	$1.49B	Buy	5,157,076 +129,172	+3%	+$35.9M	0.04%	491
2020 Q4	$1.26B	Buy	5,027,904 +110,317	+2%	+$26.3M	0.04%	505
2020 Q3	$1.11B	Sell	4,917,587 -209,018	-4%	-$43.4M	0.04%	491
2020 Q2	$894M	Sell	5,126,605 -235,189	-4%	-$37.5M	0.03%	536
2020 Q1	$677M	Buy	5,361,794 +42,418	+0.8%	+$6.36M	0.03%	558
2019 Q4	$813M	Buy	5,319,376 +43,830	+0.8%	+$6.07M	0.03%	616
2019 Q3	$698M	Buy	5,275,546 +85,424	+2%	+$11.5M	0.03%	645
2019 Q2	$736M	Sell	5,190,122 -28,461	-0.5%	-$3.86M	0.03%	634
2019 Q1	$758M	Sell	5,218,583 -64,256	-1%	-$8.44M	0.03%	595
2018 Q4	$598M	Buy	5,282,839 +68,398	+1%	+$8.56M	0.03%	630
2018 Q3	$702M	Sell	5,214,441 -32,250	-0.6%	-$3.98M	0.03%	641
2018 Q2	$589M	Buy	5,246,691 +161,284	+3%	+$17.4M	0.02%	689
2018 Q1	$543M	Buy	5,085,407 +29,537	+0.6%	+$3.18M	0.02%	717
2017 Q4	$553M	Buy	5,055,870 +62,728	+1%	+$6.83M	0.02%	706
2017 Q3	$539M	Sell	4,993,142 -67,588	-1%	-$6.94M	0.03%	687
2017 Q2	$512M	Buy	5,060,730 +27,217	+0.5%	+$2.51M	0.03%	693
2017 Q1	$453M	Buy	5,033,513 +225,563	+5%	+$19.2M	0.02%	753
2016 Q4	$366M	Buy	4,807,950 +204,507	+4%	+$15.5M	0.02%	803
2016 Q3	$384M	Buy	4,603,443 +89,674	+2%	+$7.52M	0.02%	744
2016 Q2	$372M	Buy	4,513,769 +157,711	+4%	+$13M	0.02%	723
2016 Q1	$331M	Buy	4,356,058 +173,314	+4%	+$12.8M	0.02%	752
2015 Q4	$336M	Buy	4,182,744 +97,314	+2%	+$7.02M	0.02%	740
2015 Q3	$260M	Buy	4,085,430 +71,262	+2%	+$5.12M	0.02%	840
2015 Q2	$282M	Buy	4,014,168 +69,798	+2%	+$5.17M	0.02%	860
2015 Q1	$313M	Buy	3,944,370 +64,694	+2%	+$4.77M	0.02%	791
2014 Q4	$247M	Buy	3,879,676 +9,712	+0.3%	+$609K	0.02%	855
2014 Q3	$231M	Sell	3,869,964 -19,332	-0.5%	-$1.11M	0.02%	853
2014 Q2	$208M	Buy	3,889,296 +323,447	+9%	+$17.7M	0.02%	937
2014 Q1	$215M	Buy	3,565,849 +250,685	+8%	+$14.6M	0.02%	893
2013 Q4	$176M	Buy	3,315,164 +107,313	+3%	+$5.39M	0.02%	969
2013 Q3	$148M	Buy	3,207,851 +122,499	+4%	+$5.62M	0.01%	995
2013 Q2	$127M	Buy	+3,085,352	New	+$132M	0.01%	1014